Skip to main content
SpringerLink
Log in

Aflibercept/bevacizumab/ranibizumab

Collapsing focal and segmental glomerulosclerosis: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Nobakht N, et al. Development of Collapsing Focal and Segmental Glomerulosclerosis After Receiving Intravitreal Vascular Endothelial Growth Factor Blockade. Kidney International Reports 4: 1508-1512, No. 10, Oct 2019. Available from: URL: http://doi.org/10.1016/j.ekir.2019.07.019 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aflibercept/bevacizumab/ranibizumab. Reactions Weekly 1776, 21 (2019). https://doi.org/10.1007/s40278-019-70179-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-70179-3

Search

Navigation